摘要 |
The invention concerns HER<HIL><PDAT>2</BOLD><PDAT>-transgenic non-human mammals, animal models for screening drug candidates for the treatment of diseases and disorders associated with the overexpression of HER<HIL><PDAT>2</BOLD><PDAT>. In particular, the invention concerns animal models designed to test drug candidates for the treatment of HER<HIL><PDAT>2</BOLD><PDAT>-overexpressing cancers, including breast cancer, that are not responding or poorly responding to current treatments.</PTEXT>
|